Skip to content
Search

Latest Stories

Skill mix and independent prescribing – Key to driving pharmacy forward

Skill mix and independent prescribing: The essential ingredients for pharmacy’s future

L-R: Nicola Stockmann, Robert Townsend, Atul Patel, and Amerjit Singh

“The workforce is your greatest asset,” said Nicola Stockmann, president of the Association of Pharmacy Technicians UK (APTUK).

Speaking at the recent Pharmacy Business Conference, she emphasised that investing in the entire pharmacy team, including pharmacy technicians and assistants, is essential for sustainable growth.


As one of the four panel members discussing the importance of developing independent prescribing and skill mix in pharmacy, Nicola highlighted the benefits of optimising team roles.

“By making sure the right person is doing the right thing at the right time, you can be more efficient with your services, and job satisfaction can improve across the whole team,” she said.

Nicole also stressed the need to create a conducive learning environment in pharmacies: “The pharmacy environment is where we learn, so it must be conducive to learning for everyone.”

Furthermore, Nicola said that developing independent prescribing (IP) requires collaboration from the entire team to remain agile.


Nicola Stockmann

Robert Townsend, independent prescriber at Ashington Way Pharmacy, and Atul Patel, superintendent pharmacist at Lincoln Pharmacy, echoed the importance of having a strong team to deliver services effectively.

“My team is vital to me, and I couldn’t do what I do without them,” Robert shared.

He explained how his team, including an Accuracy Checking Technician (ACT) and a trainee pharmacist, allows him to focus on patient care as an independent prescriber.

“We're moving towards enabling my two technicians to handle Pharmacy First consultations, which will allow me to concentrate on the patients who need my expertise,” he said.

Atul agreed, emphasising that having “a great team” has enabled them to offer and maximise a wide range of services, including travel vaccinations, COVID vaccinations, flu vaccinations, and stop-smoking support.

Atul believes in investing in both people and technology.

He said: "We have eight highly skilled apprentices, and we’ve invested in robotics and recently in Titan. Once everything works together, it’s going to be a game changer.”

“When we invested in technology, we didn’t reduce our staff; instead, we upsized and upskilled them.”

Independent Prescribing: progress and challenges

Atul’s pharmacy recently became an Independent Prescribing Pathfinder site, after a year of preparation. The day after going live, GP surgeries began sending out invitations to patients with uncontrolled hypertension, asthma, and mental health needs, and within one hour, all appointments were booked.

Atul held his first clinic the following day. “All patients turned up on time, were seen on time, and left very satisfied,” he shared.

However, the overwhelming demand raised concerns about sustainability.

Atul pointed out that while he managed by having one pharmacist handle the day-to-day work, and another (himself) run clinics, it’s not cost-effective without extra funding.

He suggested that scaling this model would require further investment for additional pharmacist support.

Atul reflected on an earlier experience where a clinic wanted to hire him full-time with government funding — making him question why similar investment wasn’t being made to fund pharmacists directly in their own community practices.

While pharmacists' independent prescribing is still not fully utilised, Atul acknowledged that the benefit of using them “in a proper and clinical way” has been recognised, and that “the journey is just starting.”

He also noted that the low uptake of independent prescribing is partly due to the lack of government investment in protected learning time for pharmacists.

Atul Patel,

Robert shared his independent prescribing journey, which began in 2007 — a revolutionary time when “the only medical prescribers were nurses, with just a few pharmacists working in hospitals.”

He was among four community pharmacists selected from Swindon for a pioneering NHS programme aimed at training community pharmacists to help alleviate pressure on GPs and urgent care.

He trained at Bath University and, despite feeling out of place among younger students, completed the course with strong NHS support.

Today, with 15 years of IP experience, Robert is part of a Pathfinder site and is helping to mentor and train other pharmacists.

Robert described his IP experience as a “fantastic success,” giving him “a major boost” to the second half of his career.

He takes pride in being known locally by patients for offering timely care and prescribing medicines they would otherwise wait a long time for.

Robert shared a case where he felt he had made a real difference as an independent prescriber.

“I had a young lady who had severe eczema and was quite desperate, and her GP appointment was a week away. I was able to prescribe Fucibet for her infected hands, prescribe mometasone for other affected parts, and supply some Epimax as a moisturising shower gel. I thought I made a difference there, and that's where I find real success in my role.”

However, Robert raised concerns about the future of the Pathfinder programme, noting that it might end soon due to funding uncertainties.

He warned that if the funding issue isn’t addressed, new pharmacists might leave community pharmacies for other opportunities where prescribing is better supported.

Robert Townsend


Takeaways

Atul urged attendees to “have a vision and take action to make it happen.”

He reflected on the significant technological advancements in pharmacy — from handwritten labels and typewriters to floppy disks, hard drives, and now web-based systems — but pointed out that two issues remain unchanged: the archaic remuneration system and the persistent lack of support for community pharmacies.

“Don't focus on problems, focus on solutions,” said Atul, stressing that focusing on solutions will lead to opportunities.

Nicola highlighted the importance of creating opportunities for the next generation.

“At APTUK, a key priority is making sure we don’t pull up the ladder up behind us,” she said.

“While it was difficult for us to get into our positions, we must make it easier for others. That is the true measure of progress.”

“Independent prescribing has become an integral part of pharmacy training, and accredited accuracy checking is now included in the initial education and training for pharmacy technicians - these are real measures of progress, from all of you, from all of us, to support the next generation.”

“So don't forget the impact your decisions have on the next generation,” Nicola urged.

Acknowledging that barriers still exist, she encourages pharmacy teams to focus on "what we can control" and to maintain a forward-looking mindset.

Amerjit Singh

Amerjit Singh, managing director, Sharoe Green Pharmacy/ Skills4Pharmacy, who moderated the session, concluded by stressing the importance of empowering pharmacy staff to increase the adoption of independent prescribing.

“What pharmacy technicians and ACTs do in a hospital setting is very different from what they do in the community. We must empower our staff,” he said.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less